1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Suzhou Big Vision Medical Technology Co.Ltd.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2015

Location

Suzhou Jiangsu China

Primary Industry

Healthcare Specialists

About

Established in 2015 and based in Suzhou, China, Suzhou Big Vision Medical Technology Co.Ltd. is a medical technology company that focuses on the research and development of ophthalmic disease diagnosis and analysis system. The company was founded by the young chief scientist of the National 973 Program in 2015, the R&D team consists of PhDs and Masters, and has obtained more than forty innovative achievements and patents. In May 2024, the company raised CNY 30 million in strategic investment. The company engages in the research and development of ophthalmic disease diagnosis and analysis system. Its main products include Bright Lemon, an overall solution for the optics center, MIAS, an artificial intelligence diagnosis system for ophthalmic diseases, and MIPA, an ophthalmic image processing and analysis scientific research software. Ophthalmic Disease Artificial Intelligence Diagnosis System MIAS is a software system based on image processing and artificial intelligence analysis algorithms that stores, processes and analyzes dual-modality ophthalmic images of optical coherence tomography (OCT) and fundus color photography. The company generates revenue by providing comprehensive one-stop eye health management services and selling its proprietary artificial intelligence-assisted diagnostic systems and OCT hardware devices. In the future, the company will promote the development of AI ophthalmology hardware series such as AI vision screener, AI dry eye analyzer, AI biometer, AI corneal topography.
Current Investors
Xiangshi Capital, SND Ventures Group, Agriculture Development Innovation Capital

Request a demo to show more

Primary Industry
Healthcare Specialists
Sub Industries
Optometrists & Opticians Products and Services, Diagnostic Equipment
Website
www.bigvisiontech.com
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.